VVOS   $1.31  -0.76% Market Closed After Close 1.31 0.0

Vivos Therapeutics, Inc.
Total Cash 6.90M
totalCashPerShare 2.029
EBITDA -12.90M
Total Debt 1.76M
quickRatio 1.099
currentRatio 1.182
Total Revenue 14.02M
debtToEquity 27.793
Revenue/Share 6.877
ROA -0.57001996
ROE -2.84964
grossProfits
freeCashflow -8.90M
operatingCashflow -11.11M
earningsGrowth
revenueGrowth 0.194
grossMargins 0.60074
ebitdaMargins -0.92041
operatingMargins -0.47755
profitMargins -0.859
enterpriseValue 3.87M
forwardPE -4.927273
floatShares 3.05M
sharesOutstanding 4.77M
sharesShort 69.76K
sharesShortPriorMonth 63.71K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.12%
Short Ratio help_outline 0.02%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.866
Price To Book help_outline 1.45
earningsQuarterlyGrowth
netIncomeToCommon -12.04M
trailingEps -6.80%
forwardEps -0.55%
enterpriseToEbitda -0.30
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.61 3Q 2024
institutionsCount 21
lastUpdated Nov. 7, 2024, 3:30 a.m.